OBSTRUCTIVE DISEASES

101
OBSTRUCTIVE DISEASES

description

OBSTRUCTIVE DISEASES. Causes of airway narrowing Loss of tethering Airway smooth muscle constriction Airway plugging (mucous, foreign body) Airway edema. Normal. Emphysema. Causes of airway narrowing Loss of tethering Airway smooth muscle constriction - PowerPoint PPT Presentation

Transcript of OBSTRUCTIVE DISEASES

Page 1: OBSTRUCTIVE DISEASES

OBSTRUCTIVE DISEASES

Page 2: OBSTRUCTIVE DISEASES

radius

Res

ista

nce

Causes of airway narrowing• Loss of tethering• Airway smooth muscle constriction• Airway plugging (mucous, foreign body)• Airway edema

Page 3: OBSTRUCTIVE DISEASES
Page 4: OBSTRUCTIVE DISEASES

Normal

Emphysema

Page 5: OBSTRUCTIVE DISEASES

radius

Res

ista

nce

Causes of airway narrowing• Loss of tethering• Airway smooth muscle constriction• Airway plugging (mucous, foreign body)• Airway edema

Page 6: OBSTRUCTIVE DISEASES

Air

Smooth Muscle Cell

Epithelial Cell

Page 7: OBSTRUCTIVE DISEASES

radius

Res

ista

nce

Causes of airway narrowing• Loss of tethering• Airway smooth muscle constriction• Airway plugging (mucous, foreign body)• Airway edema

Page 8: OBSTRUCTIVE DISEASES

Mucus filling the airway lumen in asthma

Page 9: OBSTRUCTIVE DISEASES

radius

Res

ista

nce

Causes of airway narrowing• Loss of tethering• Airway smooth muscle constriction• Airway plugging (mucous, foreign body)• Airway edema

Page 10: OBSTRUCTIVE DISEASES

Normal

Airway Edema

Page 11: OBSTRUCTIVE DISEASES

Measuring airway obstruction

Page 12: OBSTRUCTIVE DISEASES

time (sec)

0 1 2 3

Vol

ume

(L)

normal

airway obstruction

start expiring

FEV1.0

FVC

AIRWAY OBSTRUCTION: FEV1/FVC < 80%

Page 13: OBSTRUCTIVE DISEASES

Vo l

ume

(L)

0

time (seconds)

FRC TLC

RV

VC

VT

Page 14: OBSTRUCTIVE DISEASES

Normal values for lung volume depend on:

• Age • Sex • Height• Race• Weight (for some subdivisions of lung volume)

Page 15: OBSTRUCTIVE DISEASES

DEFINITION OF ASTHMA

1. Reversible Airway Narrowing

2. Increased Airway Responsiveness

3. Airway Inflammation

(History of Allergy)

Page 16: OBSTRUCTIVE DISEASES

Air

Smooth Muscle Cell

Epithelial Cell

Page 17: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

MUCOUS HYPERSECRETION IN ASTHMA

Page 18: OBSTRUCTIVE DISEASES

DEFINITION OF ASTHMA

1. Reversible Airway Narrowing

2. Increased Airway Responsiveness

3. Airway Inflammation

(History of Allergy)

Page 19: OBSTRUCTIVE DISEASES

Histamine (mg/ml)

.01 .03 .1 .3 1 3 10

FEV 1.

0 (%

bas

elin

e)

100

90

80

70

Normal

Asthma

AIRWAY HYPERRESPONSIVENESS

Page 20: OBSTRUCTIVE DISEASES

DEFINITION OF ASTHMA

1. Reversible Airway Narrowing

2. Increased Airway Responsiveness

3. Airway Inflammation

(History of Allergy)

Page 21: OBSTRUCTIVE DISEASES

Th2-lymphocytes• promotes IgE formation (IL-4, IL-13)• promotes eosinophil migration (IL-5)

• promotes contraction of smooth muscle• promotes recruitment of more eosinophils

Eosinophil

Page 22: OBSTRUCTIVE DISEASES

van den Toorn et al, Am. J. Respir. Crit. Care Med. 2001 164: 2107-2113

Normal

Asthma

Major Basic ProteinStaining (eosinophils)

Page 23: OBSTRUCTIVE DISEASES

Symptoms of Asthma:

• cough

• shortness of breath

• chest tightness

• wheezing

Page 24: OBSTRUCTIVE DISEASES

HISTOLOGICAL FEATURES OF ASTHMA

• Subepithelial fibrosis• Mucous cell hyperplasia• Smooth muscle hypertrophy• Increased vascularity

Page 25: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

BASEMENT MEMBRANE THICKENING IN ASTHMA

Page 26: OBSTRUCTIVE DISEASES

Ordonez et al, Am. J. Respir. Crit. Care Med. 2001 163: 517-523

INCREASED MUCOUS PRODUCING CELLS(blue purple stain)

Normal Asthma

Page 27: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

MUCOUS HYPERSECRETION IN ASTHMA

Page 28: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

AIRWAY SMOOTH MUSCLE HYPERTROPHY IN ASTHMA

Page 29: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

INCREASED AIRWAY VASCULARITY IN ASTHMA

Page 30: OBSTRUCTIVE DISEASES

Pulmonary Function

• Total lung capacity is usually normal, but the FRC is elevated and RV is increased

• Decreased FEV1/FVC ratio

• Lung stiffness is usually normal or low

• Airway obstruction is due to smooth muscle constriction and mucus hypersecretion

Page 31: OBSTRUCTIVE DISEASES

time (sec)

0 1 2 3

Vol

ume

(L)

normal

airway obstruction

start expiring

FEV1.0

FVC

AIRWAY OBSTRUCTION: FEV1/FVC < 80%

Page 32: OBSTRUCTIVE DISEASES

Vo l

ume

(L)

0

time (seconds)

FRC TLC

RV

VC

VT

asthma

Page 33: OBSTRUCTIVE DISEASES

Blood gases

• PaO2 - low because of mismatch of ventilation and perfusion

• PaCO2 • often low (hyperventilation due to anxiety)• if PaCO2 increases it’s usually a sign that

respiratory failure is approaching (patient needs to be ventilated)

Page 34: OBSTRUCTIVE DISEASES

Epidemiology of Asthma• currently affects 5-10% of US population

• incidence and severity are increasing • mortality has plateaued

• Still relatively rare

• highest in industrialized countries• Higher in urban than rural areas

Page 35: OBSTRUCTIVE DISEASES

Asthma PrevalenceUnited States, 1980-2004

0

2

4

6

8

10

12

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

2004 Year

Prev

alen

ce (%

)

Source: National Health Interview Survey; National Center for Health Statistics

12-Month

Lifetime

Attack

Current

Page 36: OBSTRUCTIVE DISEASES

IgE

Allergen

Chemicals released:

Mast cell

• histamine• leukotrienes• proteases• cytokines (IL-4, IL-5)

Page 37: OBSTRUCTIVE DISEASES

Smooth Muscle CellMast Cell(releases chemicals)

(contracts)

Page 38: OBSTRUCTIVE DISEASES

Time (hours)Allergen 1 2 3 4 5 6 7 8

100

90

80

70

60

FEV

1.0 (

% b

asel

ine)

EarlyResponse

LateResponse

Page 39: OBSTRUCTIVE DISEASES

Mast Cell

White blood cells

Page 40: OBSTRUCTIVE DISEASES

Mast Cell

Smooth Muscle Cell

Page 41: OBSTRUCTIVE DISEASES

Time (hours)Allergen 1 2 3 4 5 6 7 8

100

90

80

70

60

FEV

1.0 (

% b

asel

ine)

EarlyResponse

LateResponse

Page 42: OBSTRUCTIVE DISEASES

Allergen avoidance

Page 44: OBSTRUCTIVE DISEASES

MOST IMPORTANT ALLERGENS IN THE US

• Cat• House dust• Cockroach• Mold

Page 45: OBSTRUCTIVE DISEASES

Cat washing itself aerosolizes allergen

www.tiedye.com/cats.htm

Page 46: OBSTRUCTIVE DISEASES

Cat being washed – helps reduce allergen exposure(recommended 2X/week)

www.dkimages.com/.../Cat-Care/Cat-Care-054.html

Page 47: OBSTRUCTIVE DISEASES

100 mm

House Dust Mite - Dermatophagoides sp.

The average pillow is home to 10,000 of these!

Page 48: OBSTRUCTIVE DISEASES

Avoiding exposure to dust mite allergens

• Encase pillows and mattresses

• Use HOT (>130oC) water to wash bedding and clothes

• Reduce carpeting (in particular wall to wall carpeting, which cannot be adequately cleaned)

• Reduce humidity (mites are dependent on water in the air for their water supply)

• Avoid fabric coverings on furniture and windows

Platts-Mills et al, J Allergy Clin Immunol. 2000 Nov;106(5):787-804

Page 49: OBSTRUCTIVE DISEASES

The American cockroach

• A particular problem in low income housing• Insects move from one apartment to another

Page 50: OBSTRUCTIVE DISEASES

Mold

Page 51: OBSTRUCTIVE DISEASES

TRIGGERS FOR ASTHMA

• allergen exposure• exercise• breathing cold dry air• viral infections• irritants (ex: ozone)• occupational exposure to dust or fumes

Page 52: OBSTRUCTIVE DISEASES

PREVENTION AND TREATMENT OF ASTHMA

• Medications

• Education

• Allergen Avoidance

Page 53: OBSTRUCTIVE DISEASES

ASTHMA THERAPY

1. b-agonists2. Corticosteroids3. Leukotriene antagonists and inhibitors4. Anti-IgE

Page 54: OBSTRUCTIVE DISEASES

b-agonists

• Mimic adrenalin• Relax smooth muscle• Effects are immediate but not sustained• Provide symptom relief, but do not remove the underlying causes

Page 55: OBSTRUCTIVE DISEASES

before after before after

High resolution CT scans of airways before and after a b-agonist

New England Journal of Medicine 352:15, 2005

FEV1 Before: 1.27 L After: 1.76 L

Page 56: OBSTRUCTIVE DISEASES

Corticosteroids:

• Reduce inflammation• Improve lung function and symptoms • Decrease airway hyperresponsiveness• Reduce exacerbations• Must be taken regularly regardless of

symptoms• Not immediately effective

Page 57: OBSTRUCTIVE DISEASES

cme.med.harvard.edu/syl/fanta.html

Page 58: OBSTRUCTIVE DISEASES

Actions of Leukotrienes• Very potent constrictors of airway smooth muscle • Mucus hypersecretion • Edema formation • Eosinophil chemoattraction

Leukotriene synthesis inhibitors and receptor antagonists

• Prevent synthesis or effects of leukotrienes

Page 59: OBSTRUCTIVE DISEASES

cme.med.harvard.edu/syl/fanta.html

Page 60: OBSTRUCTIVE DISEASES

• Reduces corticosteroid requirements• Reduces symptom scores• Reduces rescue medication use• Improves lung function• Reduces exacerbations

Efficacy of anti-IgE Therapy in Humans

Fahy et al. AJRCCM 1997 155:1828

Anti-IgE therapy also:Fahy et al. AJRCCM 1997 155:1828

Page 61: OBSTRUCTIVE DISEASES

Genes

Environment

Asthma

WHAT CAUSES ASTHMA?

Page 62: OBSTRUCTIVE DISEASES

-exposure to allergens -pollution-cigarette smoke-viruses

Genes

Environment

Asthma

- cytokines- genes that regulate IgE levels- others

Page 63: OBSTRUCTIVE DISEASES
Page 64: OBSTRUCTIVE DISEASES
Page 65: OBSTRUCTIVE DISEASES

From: Camargo et al, Arch Intern Med 159:2582-2588, 1999

Page 66: OBSTRUCTIVE DISEASES
Page 67: OBSTRUCTIVE DISEASES
Page 68: OBSTRUCTIVE DISEASES

Evidence for the hygiene hypothesis

• Less asthma in individuals who grow up on farms

• Less asthma in individuals with older siblings

• Less asthma in children in daycare

Page 69: OBSTRUCTIVE DISEASES

New Engl J Med 343:538-543

Page 70: OBSTRUCTIVE DISEASES

Gold and Wright, Ann Rev Public Health, 26:89-113, 2005

Asthma is more common in the developed than the developing world

Page 71: OBSTRUCTIVE DISEASES
Page 72: OBSTRUCTIVE DISEASES

COPD – chronic obstructive pulmonary disease

• 4th leading cause of death in the US• 2nd leading cause of disability• Smokers disease• Consists of 2 diseases (many have both)

- emphysema- chronic bronchitis

Page 73: OBSTRUCTIVE DISEASES
Page 74: OBSTRUCTIVE DISEASES

Other consequences of smoking

•Heart disease•Stroke •Cancer*

*In 2000, cancer due to cigarette smoking accounted for 20% of allcancer deaths worldwide in 200

Page 75: OBSTRUCTIVE DISEASES

Consequences of passive smoking in children

• Lower birth weight in children of mothers who smoke

• Lower lung size in children of parents who smoke

• Increased incidence of asthma, bronchitis, and pneumoniain children of parents who smoke

Page 76: OBSTRUCTIVE DISEASES

From the US Department of Health and Human Services, 2003

Smoking is the leading cause of preventable death in the US

Page 77: OBSTRUCTIVE DISEASES

Year45 50 55 60 65 70 75

age

adju

sted

mor

talit

y ra

tes

(per

100

,000

)

1

10

Men Women

Page 78: OBSTRUCTIVE DISEASES
Page 79: OBSTRUCTIVE DISEASES

Thun et al, Carcinogenesis 31:100, 2010

Global burden of smoking

1.3 billion people smoke

Page 80: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

EMPHYSEMA

Page 81: OBSTRUCTIVE DISEASES

Jeffrey et al, Am. J. Respir. Crit. Care Med. 2001 164: 28S-38S

Page 82: OBSTRUCTIVE DISEASES
Page 83: OBSTRUCTIVE DISEASES

Emphysema Normal male lung

Page 84: OBSTRUCTIVE DISEASES

Mucous gland hypertrophy in chronic bronchitis

Page 85: OBSTRUCTIVE DISEASES

Pressure

Volume

Healthy

Lung Pressure Volume Curves

Emphysema

Page 86: OBSTRUCTIVE DISEASES

ETIOLOGY

Cigarette smoke (particles and chemicals)

Inflammation

Influx of activation of neutrophils and macrophages• release of proteases• release of oxygen radicals• release of inflammatory mediators

Destruction of lung tissue

Production of mucous

Airway remodeling

Page 87: OBSTRUCTIVE DISEASES
Page 88: OBSTRUCTIVE DISEASES

Signs and Symptoms

Emphysema• Dyspnea at rest• Thin• Barrel chest• Wheeze on expiration

Chronic Bronchitis• Cough • Sputum• No dyspnea at rest but does occur with exertion• Cyanosis• Frequent respiratory infections• Pops and rales

Page 89: OBSTRUCTIVE DISEASES

FEV1

(% o

f val

ue a

t age

25)

Age (years)

Never smoked orNot susceptible

Smoked regularlyAnd susceptible

Stopped at 45

Stopped at 65disability

death

25 50 75

Page 90: OBSTRUCTIVE DISEASES

Evidence for genetic susceptibility for COPD

• Familial association of low FEV1.0

• Linkage analysis studies• Genes associated with COPD susceptibility

1. a1-antitrypsin (anti-protease)2. microsomal epoxide hydrolase (degradation of chemicals in smoke) 3. glutathione-S-transferases (degradation of chemicals in smoke) 4. Hemeoxygenase 1 (antioxidant)5. TNFa (inflammation)

Page 91: OBSTRUCTIVE DISEASES

Blood gases

Emphysema• PaO2 is low but not very low

cause: V/Q mismatch• “pink puffers” - increase ventilation to keep bloodgases normal• PaCO2 is normal

Chronic Bronchitis• PaO2 usually very low

cause: V/Q mismatch and hypoventilation• “blue bloaters” – do not increase ventilation tokeep blood gases normal• PaCO2 is high

Page 92: OBSTRUCTIVE DISEASES

Chronicbronchitis

Normal

Page 93: OBSTRUCTIVE DISEASES

Consequences of low PaO2

1) Polycythemia – increased numbers of red blood cells (RBC’s)

Low PaO2

Increased erythropoetin release from kidney

Acts of bone marrow to increased production of RBC’s

2) Right heart hypertrophy (cor pulmonale)

• Due to pulmonary hypertension (hypoxic vasocontrictionand loss of capillary bed)

• Can lead to right heart failure and death

Page 94: OBSTRUCTIVE DISEASES

Cyanosis

• Occurs when deoxygenated hemoglobinexceeds 5 g/100 ml

typical total hemoglobin is 15 g/100 ml

• Low PaO2 and increased numbers of redblood cells both contribute to cyanosis in chronic bronchitis

Page 95: OBSTRUCTIVE DISEASES

Treatment

• Smoking cessation – prevents further loss of lung function

• Bronchodilators, particularly anticholinergics

• Increasing use of corticosteroids – data are not yet inregarding efficacy

• Lung reduction surgery – not usually recommended

Page 96: OBSTRUCTIVE DISEASES

Indoor air pollution – biomass fuels

Fullerton D et al Occup Env Med 66:777, 2009

Page 97: OBSTRUCTIVE DISEASES

Smith KR et al Thorax 55:518, 2000

Page 98: OBSTRUCTIVE DISEASES

Smith KR et al Thorax 55:518, 2000

US EPA 24 hour standard not to be exceeded more than once/year: 260 ug/m3

Page 99: OBSTRUCTIVE DISEASES

Indoor air pollution

• Responsible for 1.6 million deaths/year

• Disease burden worldwide exceeds outdoor air pollution 5-fold

• Most lethal killer worldwide after malnutrition, unsafe sex,lack of safe drinking water and sanitation

• Increases risk of COPD in women about 3-fold

• Responsible for 0.7 of the 2.7 million COPD deaths worldwide/year

• Burden is mostly on women and children

Source: World Health Organization

Page 100: OBSTRUCTIVE DISEASES

Hours per day near stove

Smith KR et al Thorax 55:518, 2000

Acute respiratory tract infection and exposure to biomass fuels

Page 101: OBSTRUCTIVE DISEASES

Smith KR et al Thorax 55:518, 2000